Target intelligence / Profile preview

30S ribosomal subunit (Helicobacter pylori) (30S subunit)

Target
30S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome
01

Overview

The 30S ribosomal subunit of Helicobacter pylori is a fundamental component of the bacterial translation machinery, composed of the 16S ribosomal RNA (rRNA) and approximately 21 ribosomal proteins. Its primary biological function is to initiate protein synthesis by facilitating the correct pairing of mRNA codons with tRNA anticodons, ensuring high fidelity in the decoding of the genetic message (PubMed: 12453497). In clinical medicine, this subunit is a major therapeutic target for treating H. pylori infections, which are strongly linked to the development of peptic ulcers and gastric cancer (NIH: Helicobacter pylori and Cancer). Antibiotics such as tetracycline exert their bactericidal or bacteriostatic effects by binding to the 30S subunit and physically obstructing the entry of aminoacyl-tRNA into the A-site, thereby terminating protein production (StatPearls: Tetracycline). However, the efficacy of these treatments is increasingly threatened by the emergence of resistant strains harboring specific mutations in the 16S rRNA gene, such as the AGA926-928TTC triple substitution (PubMed: 15933035). Consequently, the 30S subunit remains a focal point for the surveillance of antibiotic resistance and the design of novel antimicrobial agents intended to overcome existing resistance mechanisms.

Other names
Small ribosomal subunit16S ribosomal subunit30S ribonucleoprotein complexH. pylori 30S ribosome
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 16S rRNA of the 30S subunit, which prevents the attachment of aminoacyl-tRNA to the ribosomal A-site and halts polypeptide chain elongation.

03

Biological functions

Protein synthesisTranslation initiationmRNA decodingGenetic code translation
04

Disease associations

Helicobacter pylori infectionChronic gastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Development of antibiotic resistance due to 16S rRNA mutationsDisruption of the gastrointestinal microbiota (dysbiosis)Tetracycline-associated photosensitivityPotential for permanent tooth discoloration in childrenGastrointestinal side effects including nausea and diarrhea
06

Interacting drugs

Tetracycline

5 more in the full profile.

07

Biomarkers

16S rRNA gene mutations (e.g., AGA926-928TTC)Urea breath testStool antigen testRapid urease test

Beyond the preview

Go deeper on 30S ribosomal subunit (Helicobacter pylori) (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 30S ribosomal subunit (Helicobacter pylori) (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call